Home » Topics » Regulatory

Regulatory
RSS

Higher dose of Rebif approved in E.U. for multiple sclerosis

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

FDA approves Fragmin for DVT after hip replacement surgery

April 13, 1999

SangStat's ciclosporin capsules filed for approval in U.K.

April 12, 1999

First launch for RiboGene's intranasal metoclopramide

April 8, 1999

FDA approves ANDA for Oruvail

April 7, 1999

FDA approval granted for BioTime's blood plasma volume expander

April 6, 1999

Zeneca files sNDA for change in dosing for Zestril

April 6, 1999

FDA approves DepoCyt for treatment of lymphomatous meningitis

April 6, 1999

Prosorba Column now available in U.S. for treatment of rheumatoid arthritis

April 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...